Laser light shows promise for rare nerve pain
NCT ID NCT07661667
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether photobiomodulation (low-level laser therapy) can reduce pain and disability in people with anti-MAG neuropathy, a rare nerve condition. Ten participants will receive 16 laser sessions over six weeks. Researchers will measure changes in disability, pain, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- photobiomodulation (low-level laser therapy)
- What this could lead to
- If it works, this could offer a safe, non-drug option to reduce pain and disability from anti-MAG neuropathy.
- What could go wrong
- This is a very small, early study with only 10 participants, so results may not apply widely. The treatment aims to ease symptoms, not cure the underlying disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI MAG NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier de Cornouaille
Quimper, 29107, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.